HomeCompareCLSN vs BTI

CLSN vs BTI: Dividend Comparison 2026

CLSN yields 102.74% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CLSN wins by $4.32M in total portfolio value
10 years
CLSN
CLSN
● Live price
102.74%
Share price
$1.95
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.36M
Annual income
$1,494,304.71
Full CLSN calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — CLSN vs BTI

📍 CLSN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLSNBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLSN + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLSN pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLSN
Annual income on $10K today (after 15% tax)
$8,733.18/yr
After 10yr DRIP, annual income (after tax)
$1,270,159.00/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, CLSN beats the other by $1,267,777.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLSN + BTI for your $10,000?

CLSN: 50%BTI: 50%
100% BTI50/50100% CLSN
Portfolio after 10yr
$2.20M
Annual income
$748,553.49/yr
Blended yield
34.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

CLSN
Analyst Ratings
6
Buy
2
Hold
1
Sell
Consensus: Buy
Altman Z
-7819.1
Piotroski
3/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLSN buys
0
BTI buys
0
No recent congressional trades found for CLSN or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLSNBTI
Forward yield102.74%5.40%
Annual dividend / share$2.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$4.36M$37.8K
Annual income after 10y$1,494,304.71$2,802.29
Total dividends collected$3.90M$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyBuy

Year-by-year: CLSN vs BTI ($10,000, DRIP)

YearCLSN PortfolioCLSN Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$20,974$10,274.32$11,301$601.08+$9.7KCLSN
2$42,582$20,139.91$12,799$706.58+$29.8KCLSN
3$83,777$38,213.45$14,527$832.38+$69.3KCLSN
4$159,904$70,262.72$16,527$982.75+$143.4KCLSN
5$296,433$125,336.27$18,846$1,162.95+$277.6KCLSN
6$534,334$217,150.75$21,545$1,379.49+$512.8KCLSN
7$937,555$365,816.85$24,694$1,640.41+$912.9KCLSN
8$1,603,062$599,878.65$28,378$1,955.69+$1.57MCLSN
9$2,673,868$958,591.11$32,702$2,337.79+$2.64MCLSN
10$4,355,343$1,494,304.71$37,794$2,802.29+$4.32MCLSN

CLSN vs BTI: Complete Analysis 2026

CLSNStock

Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.

Full CLSN Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this CLSN vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLSN vs SCHDCLSN vs JEPICLSN vs OCLSN vs KOCLSN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.